Chlormethiazole ethanedisulphonate (Hemineurin) was administered to provide light sedation in patients undergoing surgery with neural blockade. A two stage intravenous infusion system was used and consisted of a loading dose 1520 mg over 30 minutes followed by a maintenance rate of 10 mg/minfor the desired period. Patients were sedated smoothly and reliably but could be roused by verbal contact. Recovery from effects was rapid and this is a result of a high clearance of chlormethiazole from the body (approximately 2 IImin). Blood concentrations of chlormethiazole (base, mean ± SD) associated with light sedation were 5.5 ± 3.0 mg/l, while a sleep-like state was achieved with concentrations of 6. 7 ± 3.0 mg/I. Given by controlled intravenous infusion under close supervision, chlormethiazole appears close to being an ideal sedative to supplement neural blockade techniques.
expected to be beneficial when used in conjunction with regional anaesthetic techniques.
The present study was designed to extend previous clinical studies by measuring chlormethiazole blood concentrations to obtain data on the relationship between these and clinical response and to obtain preliminary estimates of chlormethiazole clearance in surgical patients.
METHODS
Eight patients were studied, five of whom were given spinal and three epidural neural blockade for lower limb or urological surgery. Neural blockade to approximately T 10 level was established and then chlormethiazole infusion was commenced.
A chlormethiazole infusion was designed to produce a blood concentration of Description of patients, their surgery, anaesthesia, chlormethiazole infusion period and blood sampling time. PATIENT Blood samples for chlormethiazole concentration were obtained at 10 minute intervals during both loading and maintenance infusions and for at least 30 minutes after the cessation of infusion (Table 1. ) Chlormethiazole was determined by the gas chromatographic method of Mather and Tucker 5 and using a nitrogen detector in place of the flame ionization detector. Bromethiazole was used as an internal standard. Blood concentrations are expressed as chlormethiazole base (8.0 mg chlormethiazole ethanedisulphonate is equivalent to 5.12 mg chlormethiazole base).
Pharmacokinetic parameters were estimated from the entire set of blood concentration-time data using the method of Mather, Ringrose and Austin. 6 
RESULTS
Individual patient response data and blood chlormethiazole concentration-time data are shown in Tables 2 and 3 . There were no systematic differences between the patients undergoing subarachnoid block, epidural block or general anaesthesia. In general, effective blood concentrations were achieved rapidly with the loading dose regimen. Patients became sedated in approximately 10-20 minutes and usually passed into a stage of light sleep between 20-30 minutes but were readily rousable. Patients regained consciousness within approximately seven minutes of cessation of infusion. The two patients undergoing general anaesthesia also had the longest times to regaining consciousness but their chlormethiazole blood concentrations were not different from those of the other patients.
There was a two-to threefold range of blood concentrations associated with sedation and this probably reflects the indeterminate nature of a 'sedation' reference point. greater than the sedation state. Thus it appears that the preliminary estimate of effective concentration (4.0 mg/l) was a little too low and that blood concentrations of approximately 5-7.0 mg/l should be sought. Two cases required the prone position and the sedation produced by chlormethiazole in no way interfered with respiration or airway maintenance. All patients recovered rapidly and were alert after the infusion.
Blood concentration-time data were fitted to a bi-exponential equation describing the two compartment model disposition according to the known pharmacokinetic characteristics of chlormethiazole. 4 However, the duration of sampling was generally insufficient to accurately characterise the properties of a two compartment model, especially the slow halflife in the elimination phase. Hence the model was reduced to a one compartment system from L. E. MA THER AND M. J. COUSINS which total body clearance was derived ( Table  3 , Figure 1 ). This ranged from 0.6 to over 3.0 lImin with the average being approximately 2.0 lImin and without systematic differences according to type of anaesthesia used. 
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DISCUSSION
The agent appeared excellent for supplementation of central neural blockade. Cardiovascular stability was maintained during the infusion despite the presence of T 10 blockade. There were no excitatory movements and patients did not awaken periodically with 'startle' reactions as seen with some sedative regimens (e.g. diazepam). Some patients when roused wanted to know when the surgery was to start when, in fact, it was completed.
The total body clearance (average approximately 2.0 lImin) is similar to reported values in healthy volunteers 4 and is similar to hepatic blood flow in normal man. However, volumes of distribution and half-lives, because of the blood sampling schedule used, are not reported.
A high total body clearance is an important property for intravenous sedative agents because it allows blood concentrations and therefore clinical response to be altered quickly. This is analogous to the rapid alterations that can be produced quickly by using the lungs to excrete the volatile anaesthetic agents. A number of authors 7 • 8 have advocated the use of diazepam for this purpose. However, the total body clearance of diazepam is only 0.02-0.03 lImin while the half-life is 1-2 days in normal man. 9 Hence diazepam elimination is slow and blood concentrations change only slowly. Therefore recovery from diazepam sedation is slow.
The infusion regimen used in this study was not ideal for routine clinical use when combined with central neural blockade because the loading phase was too prolonged. However, with modifications to achieve the effective blood concentrations more rapidly, an infusion regimen can be designed to maintain the blood concentrafions accurately within narrow clinical limits. Studies are in progress to accomplish this goal.
Chlormethiazole is an old drug with anticonvulsant and sedative properties both of which effects are desirable for supplementation of neural blockade. In addition it provides a mild elevation of heart rate which antagonises the tendency to bradycardia during central neural blockade. It has been maligned because of inappropriate use in the treatment of alcoholism, largely as a result of failure of some clinicians to recognise that it is potentially a potent anaesthetic agent. Given by controlled intravenous infusion under close supervision it appears close to being an ideal sedative to supplement neural blockade techniques.
CONCLUSIONS
The ideal intravenous sedative with high clearance and rapid onset/offset of action has yet to be described. Chlormethiazole given by infusion produced sedation smoothly and reliably. It had a high total body clearance allowing patients to wake soon after cessation of administration. ADDENDUM It has been shown recently that a significant proportion (up to 30070) of chlormethiazole may be absorbed by the plastic tubing of infusion sets during administration. 10 The effects of this uncertain amount of dose reduction are difficult to estimate but would certainly lead to a falsely high total body clearance (cL Table 3 ). studies. Mr. C. McLean is especially thanked for technical assistance.
